High-dose chemotherapy and autologous stem cell transplantation in elderly primary CNS lymphoma patients - retrospective chart review

• Conditions: C85.9; Non-Hodgkin lymphoma, unspecified

• Registration Number: DRKS00009037
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-08-17
• Study Completion: 2017-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Immunocompetent patients with biopsy proven PCNSL who underwent HDT-ASCT, age at diagnosis >/=65 years

Exclusion Criteria

Congenital or acquired immunodeficiency, age < 65 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression Free Survival (PFS)<br>

Secondary Outcome Measures

Name	Time	Method
Remission status before HCT-ASCT<br>Adverse events during HCT-ASCT<br>Remission status after HCT-ASCT<br>Overall Survival (OS)